A Study of CC-97540 in Participants With Severe, Refractory Systemic Lupus Erythematosus (SLE)
Status:
Not yet recruiting
Trial end date:
2028-02-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the tolerability, preliminary efficacy, and
pharmacokinetics of CC-97540 in participants with severe, refractory Systemic Lupus
Erythematosus (SLE).